KAITLYN BERANEK: Open Payments
NPI 1477992071 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 67 payments from 11 companies in 2025. Trend: 2023 $374 · 2024 $390 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $244 |
| Novartis Pharmaceuticals Corporation | 6 | $88 |
| Astellas Pharma US Inc | 2 | $58 |
| PFIZER INC. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 5 | $29 |
| Medtronic, Inc. | 1 | $28 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| KYOWA KIRIN, INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VRAYLAR, LEQVIO, Veozah, UBRELVY, PREVNAR 20, VOQUEZNA, SYMPLICITY G3, Xeomin.
Industry payments across NE — which companies pay providers there.
